- Home
- INM
INM
InMed Pharmaceuticals Inc.
as 07-26-2024 4:00pm EST
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.21 - $2.08 | Next Earning Date: | 09-11-2024 |
| Revenue: | $5,625,728 | Revenue Growth: | 140.49% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of InMed Pharmaceuticals Inc. (INM)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HULL ANDREW | INM | Director | Feb 21 '24 | Buy | $0.39 | 37,500 | $14,625.00 | 38,258 | SEC Form 4 |
| ADAMS ERIC A | INM | President & CEO | Feb 20 '24 | Buy | $0.36 | 41,600 | $14,921.92 | 43,959 | SEC Form 4 |
Latest InMed Pharmaceuticals Inc. News
INM Breaking Stock News: Dive into INM Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
Newsfile
2 months ago
InMed to Present at the Emerging Growth Conference
Business Wire
2 months ago
Net Asset Value(s)
Business Wire
2 months ago
MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
Newsfile
2 months ago
RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
GlobeNewswire
2 months ago
Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%
PR Newswire
2 months ago
Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
PR Newswire
2 months ago
Dstny honored with 'Employee Wellbeing Award'
Compare INM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INM InMed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.